RU2449796C9 - Фармацевтическая комбинация этинилэстрадиола и дроспиренона для использования в качестве контрацептива - Google Patents

Фармацевтическая комбинация этинилэстрадиола и дроспиренона для использования в качестве контрацептива

Info

Publication number: RU2449796C9
Authority: RU; Russia
Prior art keywords: drospirenone; ethynylestradiol; combination; active agent; daily
Prior art date: 1999-08-31

Application number

RU2002107987/15A

Other languages

English (en)

Other versions

RU2269342C9 (ru

RU2002107987A (ru

RU2449796C2 (ru

Inventor

Вольфганг ХАЙЛЬ (DE)

Юрген ХИЛЬМАН (DE)

Ральф ЛИПП (DE)

Ренате ХАЙТХЕККЕР (DE)

Original Assignee

Shering Aktsiengezell Shaft

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-08-31

Filing date

2000-08-31

Publication date

2007-10-27

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26153358&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RU2449796(C9) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2000-08-31 Application filed by Shering Aktsiengezell Shaft filed Critical Shering Aktsiengezell Shaft

2004-12-27 Publication of RU2002107987A publication Critical patent/RU2002107987A/ru

2006-02-10 Application granted granted Critical

2006-02-10 Publication of RU2449796C2 publication Critical patent/RU2449796C2/ru

2007-10-27 Publication of RU2449796C9 publication Critical patent/RU2449796C9/ru

2007-10-27 Publication of RU2269342C9 publication Critical patent/RU2269342C9/ru

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

RU2002107987/15A 1999-08-31 2000-08-31 Фармацевтическая комбинация этинилэстрадиола и дроспиренона для использования в качестве контрацептива RU2269342C9 (ru)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date
US24095399P	1999-08-31	1999-08-31
EP99202826		1999-08-31
US60/240,953		1999-08-31
EP99202826.6		1999-08-31
US09/386,274		1999-08-31

Related Child Applications (1)

Application Number	Title	Priority Date	Filing Date
RU2005131868/15A Division RU2396082C2 (ru)	1999-08-31	2005-10-14	Многофазный фармацевтический препарат для ингибирования овуляции у млекопитающего

Publications (4)

Publication Number	Publication Date
RU2002107987A RU2002107987A (ru)	2004-12-27
RU2449796C2 RU2449796C2 (ru)	2006-02-10
RU2449796C9 true RU2449796C9 (ru)	2007-10-27
RU2269342C9 RU2269342C9 (ru)	2007-10-27

Family

ID=26153358

Family Applications (4)

Application Number	Title	Priority Date	Filing Date
RU2002107987/15K RU2269342C2 (ru)	1999-08-31	2000-08-31	Фармацевтическая комбинация этинилэстрадиола и дроспиренона для использования в качестве контрацептива
RU2002107987/15A RU2269342C9 (ru)	1999-08-31	2000-08-31	Фармацевтическая комбинация этинилэстрадиола и дроспиренона для использования в качестве контрацептива
RU2005131868/15A RU2396082C2 (ru)	1999-08-31	2005-10-14	Многофазный фармацевтический препарат для ингибирования овуляции у млекопитающего
RU2010114825/15A RU2482853C2 (ru)	1999-08-31	2010-04-14	Фармацевтическая композиция, способ ее получения и многофазный фармацевтический препарат для ингибирования овуляции у млекопитающего

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
RU2002107987/15K RU2269342C2 (ru)	1999-08-31	2000-08-31	Фармацевтическая комбинация этинилэстрадиола и дроспиренона для использования в качестве контрацептива

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
RU2005131868/15A RU2396082C2 (ru)	1999-08-31	2005-10-14	Многофазный фармацевтический препарат для ингибирования овуляции у млекопитающего
RU2010114825/15A RU2482853C2 (ru)	1999-08-31	2010-04-14	Фармацевтическая композиция, способ ее получения и многофазный фармацевтический препарат для ингибирования овуляции у млекопитающего

Country Status (11)

Country	Link
CN (1)	CN1223350C (ru)
BG (2)	BG65204B1 (ru)
CA (1)	CA2382426C (ru)
EE (1)	EE05317B1 (ru)
HR (1)	HRP20020258B1 (ru)
IL (2)	IL197396A (ru)
MX (1)	MXPA02002043A (ru)
NO (3)	NO327588B3 (ru)
RU (4)	RU2269342C2 (ru)
SK (1)	SK287634B6 (ru)
UA (1)	UA81387C2 (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1625849A1 (en) *	2004-08-09	2006-02-15	Liconsa, Liberacion Controlada de Sustancias Activas, S.A.	Pharmaceutical composition comprising drospirenone and ethynylestradiol
CN101489563A (zh) *	2006-07-06	2009-07-22	拜耳先灵医药股份有限公司	用于避孕和预防先天性畸形风险的药物制剂
PT2782584T (pt)	2011-11-23	2021-09-02	Therapeuticsmd Inc	Preparações e terapias de substituição para hormonoterapias naturais combinadas
US9301920B2 (en)	2012-06-18	2016-04-05	Therapeuticsmd, Inc.	Natural combination hormone replacement formulations and therapies
RU2618471C2 (ru) *	2012-12-03	2017-05-03	Закрытое Акционерное Общество "Вертекс"	Пероральная фармацевтическая композиция диуретика и ингибитора АПФ в микронизированной форме, лекарственное средство и его применение
US11266661B2 (en)	2012-12-21	2022-03-08	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US10206932B2 (en)	2014-05-22	2019-02-19	Therapeuticsmd, Inc.	Natural combination hormone replacement formulations and therapies
CN108606963B (zh) *	2017-12-27	2021-05-18	上海长海医院	含有屈螺酮和雌激素的复方避孕贴、制备方法及应用
CN111529482A (zh) *	2020-05-20	2020-08-14	祝培	十一酸睾酮缓释植入剂及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2652761C2 (de) *	1976-11-16	1985-11-21	Schering AG, 1000 Berlin und 4709 Bergkamen	15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE4344462C2 (de) *	1993-12-22	1996-02-01	Schering Ag	Zusammensetzung für die Empfängnisverhütung
DE4411585A1 (de) *	1994-03-30	1995-10-05	Schering Ag	Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
BR9710566A (pt) *	1996-07-26	1999-08-17	American Home Prod	M-todo anticoncepcional monof sico e um kit compreendendo uma combina-Æo de uma progestina e estrog-nio

2000
- 2000-08-31 RU RU2002107987/15K patent/RU2269342C2/ru not_active IP Right Cessation
- 2000-08-31 UA UA2002032519A patent/UA81387C2/xx unknown
- 2000-08-31 SK SK257-2002A patent/SK287634B6/sk not_active IP Right Cessation
- 2000-08-31 EE EEP200900049A patent/EE05317B1/xx not_active IP Right Cessation
- 2000-08-31 CN CNB008150540A patent/CN1223350C/zh not_active Expired - Lifetime
- 2000-08-31 RU RU2002107987/15A patent/RU2269342C9/ru not_active IP Right Cessation
- 2000-08-31 MX MXPA02002043A patent/MXPA02002043A/es active IP Right Grant
- 2000-08-31 CA CA002382426A patent/CA2382426C/en not_active Expired - Lifetime
2002
- 2002-03-20 BG BG106533A patent/BG65204B1/bg unknown
- 2002-03-20 BG BG109749A patent/BG109749A/bg unknown
- 2002-03-27 HR HR20020258A patent/HRP20020258B1/xx not_active IP Right Cessation
2005
- 2005-10-14 RU RU2005131868/15A patent/RU2396082C2/ru active
2008
- 2008-09-08 NO NO20083854A patent/NO327588B3/no not_active IP Right Cessation
2009
- 2009-03-04 IL IL197396A patent/IL197396A/en active IP Right Grant
- 2009-05-07 NO NO20091809A patent/NO20091809L/no not_active Application Discontinuation
- 2009-08-19 IL IL200482A patent/IL200482A0/en unknown
2010
- 2010-02-26 NO NO2010004C patent/NO2010004I1/no unknown
- 2010-04-14 RU RU2010114825/15A patent/RU2482853C2/ru active

Also Published As

Publication number	Publication date
CN1407895A (zh)	2003-04-02
NO327588B1 (no)	2009-08-31
RU2396082C2 (ru)	2010-08-10
SK2572002A3 (en)	2002-11-06
BG65204B1 (bg)	2007-07-31
NO20091809L (no)	2002-04-26
RU2010114825A (ru)	2011-10-20
IL197396A (en)	2010-04-29
RU2269342C9 (ru)	2007-10-27
RU2482853C2 (ru)	2013-05-27
HRP20020258B1 (en)	2007-05-31
NO2010004I1 (no)	2010-03-22
EE200900049A (et)	2009-10-15
NO327588B3 (no)	2011-05-16
CA2382426A1 (en)	2001-03-08
BG106533A (bg)	2002-10-31
IL200482A0 (en)	2011-07-31
MXPA02002043A (es)	2003-08-20
SK287634B6 (sk)	2011-04-05
UA81387C2 (en)	2008-01-10
BG109749A (bg)	2008-06-30
CA2382426C (en)	2006-02-28
RU2005131868A (ru)	2007-04-20
RU2269342C2 (ru)	2006-02-10
EE05317B1 (et)	2010-08-16
NO20083854L (no)	2002-04-26
RU2449796C2 (ru)	2006-02-10
CN1223350C (zh)	2005-10-19
HRP20020258A2 (en)	2005-02-28

Publication	Publication Date	Title
CA1198057A (en)	1985-12-17	Method of contraception using peak progestogen dosage
CA2003524C (en)	1999-10-19	Treatment of obesity
FI98985C (fi)	1997-09-25	Ehkäisyvalmiste
YU14502A (sh)	2006-01-16	Farmaceutska kombinacija etinilestradiola i drospirenona za primenu kao kontraceptivnog sredstva
RU2002122113A (ru)	2004-03-10	Дроспиренон для гормональной заместительной терапии
CA2240329A1 (en)	1999-01-14	Improved delivery of multiple doses of medications
WO2005065069A3 (en)	2005-09-22	Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease
MY144021A (en)	2011-07-29	Pharmaceutical delivery system
RU2449796C9 (ru)	2007-10-27	Фармацевтическая комбинация этинилэстрадиола и дроспиренона для использования в качестве контрацептива
CA2570474A1 (en)	2006-01-12	A combination composition comprising paracetamol and ibuprofen
MY124465A (en)	2006-06-30	Reduction of infarct volume using citicoline
NZ307178A (en)	2000-01-28	Medicament for contraception; contains two, separately packed, sequential hormonal components
IL135235A0 (en)	2001-05-20	Method and composition for preventing nephrotoxicity caused by cyclosporins and tacrolimus
KR970706004A (ko)	1997-11-03	호르몬 약물 및 에스트로겐 결핍을 치유하기 위한 그의 용도(novel hormonal medicaments and use thereof for correcting oestrogen deficiencies)
AR035946A1 (es)	2004-07-28	Composiciones farmaceuticas estrogenicas para usar en el tratamiento de desordenes en mujeres perimenopausicas, menopausicas o posmenopausicas, y usos de dichas composiciones para la preparacion de medicamentos
EP0235090B1 (en)	1993-09-15	Composition useful in the treatment of estrogen deficiencies
KR100420673B1 (ko)	2004-07-23	지연된구토반응을치료하기위한비강투여제
PL348202A1 (en)	2002-05-06	Pharmaceutically active composition and dispensing device
RU2002107987A (ru)	2004-12-27	Фармацевтическая комбинация этинилэстрадиола и дроспиренона для использования в качестве контрацептива
FI83593B (fi)	1991-04-30	Antikonceptionssammansaettning.
US20080268022A1 (en)	2008-10-30	Mehtods for treating and preventing ailments caused by human papillomavirus
KR890014109A (ko)	1989-10-21	의약제
TW200640468A (en)	2006-12-01	Pharmaceutical product for oral contraception
NZ315632A (en)	1999-11-29	Process for preparing solid dosage forms of very low-dose drugs comprising admixing 1-3% by weight of carrier particles with a solution of drug in water
CA2248841A1 (en)	1997-09-18	Sequential oestrogen/progesterone antagonist combination for hormone replacement therapy

Legal Events

Date	Code	Title	Description
2007-04-20	TK4A	Correction to the publication in the bulletin (patent)	Free format text: AMENDMENT TO CHAPTER -FG4A- IN JOURNAL: 4-2006 FOR TAG: (30)
2007-10-27	TH4A	Reissue of patent specification
2009-10-27	PD4A	Correction of name of patent owner
2012-07-10	PD4A	Correction of name of patent owner
2014-10-27	RZ4A	Other changes in the information about an invention
2015-03-10	TK4A	Correction to the publication in the bulletin (patent)	Free format text: AMENDMENT TO CHAPTER -FG4A- IN JOURNAL: 13-2012
2015-04-20	RZ4A	Other changes in the information about an invention
2015-06-10	MF4A	Cancelling an invention patent